BRIDGETTE JEFFRIES: Open Payments
NPI 1740753854 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,037 in 68 payments from 13 companies in 2025. Trend: 2023 $1,714 · 2024 $4,351 · 2025 $2,037
Food & beverage: $1,868Travel & lodging: $168
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $529 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $321 |
| Teva Pharmaceuticals USA, Inc. | 4 | $260 |
| ABBVIE INC. | 12 | $204 |
| Axsome Therapeutics, Inc. | 7 | $179 |
| Otsuka America Pharmaceutical, Inc. | 8 | $142 |
| Tris Pharma Inc | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
Products named: SPRAVATO, CAPLYTA, VRAYLAR, Auvelity, INVEGA SUSTENNA, UZEDY, REXULTI, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
